keyword
https://read.qxmd.com/read/34635437/metabolic-perturbations-mediated-by-propionyl-coa-accumulation-in-organs-of-mouse-model-of-propionic-acidemia
#41
JOURNAL ARTICLE
Wentao He, You Wang, Erik J Xie, Michael A Barry, Guo-Fang Zhang
Propionic acidemia (PA) is an autosomal recessive metabolic disorder after gene encoding propionyl-CoA carboxylase, Pcca or Pccb, is mutated. This genetic disorder could develop various complications which are ascribed to dysregulated propionyl-CoA metabolism in organs. However, the effect of attenuated PCC on propionyl-CoA metabolism in different organs remains to be fully understood. We investigated metabolic perturbations in organs of Pcca-/- (A138T) mice (a mouse model of PA) under chow diet and acute administration of [13 C3 ]propionate to gain insight into pathological mechanisms of PA...
November 2021: Molecular Genetics and Metabolism
https://read.qxmd.com/read/34578284/multi-organ-histopathological-changes-in-a-mouse-hepatitis-virus-model-of-covid-19
#42
JOURNAL ARTICLE
Michael J Paidas, Adhar B Mohamed, Michael D Norenberg, Ali Saad, Ariel Faye Barry, Cristina Colon, Norma Sue Kenyon, Arumugam R Jayakumar
Infection with SARS-CoV-2, the virus responsible for the global COVID-19 pandemic, causes a respiratory illness that can severely impact other organ systems and is possibly precipitated by cytokine storm, septic shock, thrombosis, and oxidative stress. SARS-CoV-2 infected individuals may be asymptomatic or may experience mild, moderate, or severe symptoms with or without pneumonia. The mechanisms by which SARS-CoV-2 infects humans are largely unknown. Mouse hepatitis virus 1 (MHV-1)-induced infection was used as a highly relevant surrogate animal model for this study...
August 27, 2021: Viruses
https://read.qxmd.com/read/34564517/transmigration-across-a-steady-state-blood-brain-barrie-induces-activation-of-circulating-dendritic-cells-partly-mediated-by-actin-cytoskeletal-reorganization
#43
JOURNAL ARTICLE
Megha Meena, Mats Van Delen, Maxime De Laere, Ann Sterkens, Coloma Costas Romero, Zwi Berneman, Nathalie Cools
The central nervous system (CNS) is considered to be an immunologically unique site, in large part given its extensive protection by the blood-brain barrier (BBB). As our knowledge of the complex interaction between the peripheral immune system and the CNS expands, the mechanisms of immune privilege are being refined. Here, we studied the interaction of dendritic cells (DCs) with the BBB in steady-state conditions and observed that transmigrated DCs display an activated phenotype and stronger T cell-stimulatory capacity as compared to non-migrating DCs...
September 13, 2021: Membranes
https://read.qxmd.com/read/34547333/pharmacokinetics-and-pharmacodynamics-of-the-synthetic-cannabinoid-5f-mdmb-pica-in-male-rats
#44
JOURNAL ARTICLE
Alex J Krotulski, Nancy Garibay, Donna Walther, Sara E Walton, Amanda L A Mohr, Barry K Logan, Michael H Baumann
5F-MDMB-PICA is a popular synthetic cannabinoid associated with analytically confirmed intoxications. In vitro studies show 5F-MDMB-PICA is a potent cannabinoid-1 receptor (CB1 ) agonist, but little information is available about in vivo pharmacokinetics and pharmacodynamics. To this end, the present study had three aims: 1) to develop a validated method for detection of 5F-MDMB-PICA and its metabolites in rat plasma, 2) to utilize the method for investigating pharmacokinetics of 5F-MDMB-PICA in rats, and 3) to relate 5F-MDMB-PICA pharmacokinetics to pharmacodynamic effects...
November 1, 2021: Neuropharmacology
https://read.qxmd.com/read/34543687/kidney-disease-hypertension-treatment-and-cerebral-perfusion-and-structure
#45
RANDOMIZED CONTROLLED TRIAL
Manjula Kurella Tamura, Sarah Gaussoin, Nicholas M Pajewski, Greg Zaharchuk, Barry I Freedman, Stephen R Rapp, Alexander P Auchus, William E Haley, Suzanne Oparil, Jessica Kendrick, Christianne L Roumie, Srinivasan Beddhu, Alfred K Cheung, Jeff D Williamson, John A Detre, Sudipto Dolui, R Nick Bryan, Ilya M Nasrallah
RATIONALE & OBJECTIVE: The safety of intensive blood pressure (BP) targets is controversial for persons with chronic kidney disease (CKD). We studied the effects of hypertension treatment on cerebral perfusion and structure in individuals with and without CKD. STUDY DESIGN: Neuroimaging substudy of a randomized trial. SETTING & PARTICIPANTS: A subset of participants in the Systolic Blood Pressure Intervention Trial (SPRINT) who underwent brain magnetic resonance imaging studies...
May 2022: American Journal of Kidney Diseases
https://read.qxmd.com/read/34438102/the-clinical-use-of-serum-biomarkers-in-traumatic-brain-injury-a-systematic-review-stratified-by-injury-severity
#46
JOURNAL ARTICLE
Nadeem Al-Adli, Omar S Akbik, Benjamin Rail, Eric Montgomery, Christie Caldwell, Umaru Barrie, Shaleen Vira, Mazin Al Tamimi, Carlos A Bagley, Salah G Aoun
BACKGROUND: Serum biomarkers have gained significant popularity as an adjunctive measure in the evaluation and prognostication of traumatic brain injury (TBI). However, a concise and clinically oriented report of the major markers in function of TBI severity is lacking. This systematic review aims to report current data on the diagnostic and prognostic utility of blood-based biomarkers across the spectrum of TBI. METHODS: A literature search of the PubMed/Medline electronic database was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines...
November 2021: World Neurosurgery
https://read.qxmd.com/read/34315111/ccl5-via-gpx1-activation-protects-hippocampal-memory-function-after-mild-traumatic-brain-injury
#47
JOURNAL ARTICLE
Man-Hau Ho, Chia-Hung Yen, Tsung-Hsun Hsieh, Tzu-Jen Kao, Jing-Yuan Chiu, Yung-Hsiao Chiang, Barry J Hoffer, Wen-Chang Chang, Szu-Yi Chou
Traumatic brain injury (TBI) is a prevalent head injury worldwide which increases the risk of neurodegenerative diseases. Increased reactive oxygen species (ROS) and inflammatory chemokines after TBI induces secondary effects which damage neurons. Targeting NADPH oxidase or increasing redox systems are ways to reduce ROS and damage. Earlier studies show that C-C motif chemokine ligand 5 (CCL5) has neurotrophic functions such as promoting neurite outgrowth as well as reducing apoptosis. Although CCL5 levels in blood are associated with severity in TBI patients, the function of CCL5 after brain injury is unclear...
October 2021: Redox Biology
https://read.qxmd.com/read/34145064/enhancing-target-tissue-levels-and-diminishing-plasma-clearance-of-ionizing-zwitterionic-antidotes-in-organophosphate-exposures
#48
JOURNAL ARTICLE
Yan-Jye Shyong, Yadira Sepulveda, Arnold Garcia, Nathan M Samskey, Zoran Radic, Rakesh K Sit, K Barry Sharpless, Jeremiah D Momper, Palmer Taylor
Inhibition of acetylcholinesterase (AChE) by certain organophosphates (OPs) can be life-threatening and requires reactivating antidote accessibility to the peripheral and central nervous systems to reverse symptoms and enhance survival parameters. In considering dosing requirements for oxime antidotes in OP exposures that inactivate AChE, clearance of proton ionizable, zwitterionic antidotes is rapid and proceeds with largely the parent antidotal compound being cleared by renal transporters. Such transporters may also control disposition between target tissues and plasma as well as overall elimination from the body...
September 2021: Journal of Pharmacology and Experimental Therapeutics
https://read.qxmd.com/read/34128530/studying-human-nociceptors-from-fundamentals-to-clinic
#49
REVIEW
Steven J Middleton, Allison M Barry, Maddalena Comini, Yan Li, Pradipta R Ray, Stephanie Shiers, Andreas C Themistocleous, Megan L Uhelski, Xun Yang, Patrick M Dougherty, Theodore J Price, David L Bennett
Chronic pain affects one in five of the general population and is the third most important cause of disability-adjusted life-years globally. Unfortunately, treatment remains inadequate due to poor efficacy and tolerability. There has been a failure in translating promising preclinical drug targets into clinic use. This reflects challenges across the whole drug development pathway, from preclinical models to trial design. Nociceptors remain an attractive therapeutic target: their sensitization makes an important contribution to many chronic pain states, they are located outside the blood-brain barrier, and they are relatively specific...
June 22, 2021: Brain
https://read.qxmd.com/read/34059796/reduced-adult-neurogenesis-is-associated-with-increased-macrophages-in-the-subependymal-zone-in-schizophrenia
#50
JOURNAL ARTICLE
Christin Weissleder, Hayley F North, Maina Bitar, Janice M Fullerton, Rachel Sager, Guy Barry, Michael Piper, Glenda M Halliday, Maree J Webster, Cynthia Shannon Weickert
Neural stem cells in the human subependymal zone (SEZ) generate neuronal progenitor cells that can differentiate and integrate as inhibitory interneurons into cortical and subcortical brain regions; yet the extent of adult neurogenesis remains unexplored in schizophrenia and bipolar disorder. We verified the existence of neurogenesis across the lifespan by chartering transcriptional alterations (2 days-103 years, n = 70) and identifying cells indicative of different stages of neurogenesis in the human SEZ...
May 31, 2021: Molecular Psychiatry
https://read.qxmd.com/read/33956289/regulation-of-arsenic-methylation-identification-of-the-transcriptional-region-of-the-human-as3mt-gene
#51
JOURNAL ARTICLE
Kunie Yoshinaga-Sakurai, Toby G Rossman, Barry P Rosen
The human enzyme As(III) S-adenosylmethionine methyltransferase (AS3MT) catalyzes arsenic biotransformations and is considered to contribute to arsenic-related diseases. AS3MT is expressed in various tissues and cell types including liver, brain, adrenal gland, and peripheral blood mononuclear cells but not in human keratinocytes, urothelial, or brain microvascular endothelial cells. This indicates that AS3MT expression is regulated in a tissue/cell type-specific manner, but the mechanism of transcriptional regulation of expression of the AS3MT gene is not known...
May 6, 2021: Cell Biology and Toxicology
https://read.qxmd.com/read/33897587/preliminary-evidence-of-orthostatic-intolerance-and-altered-cerebral-vascular-control-following-sport-related-concussion
#52
JOURNAL ARTICLE
Morgan L Worley, Morgan C O'Leary, James R Sackett, Zachary J Schlader, Barry Willer, John J Leddy, Blair D Johnson
Concussions have been shown to result in autonomic dysfunction and altered cerebral vascular function. We tested the hypothesis that concussed athletes (CA) would have altered cerebral vascular function during acute decreases and increases in blood pressure compared to healthy controls (HC). Ten CA (age: 20 ± 2 y, 7 females) and 10 HC (age: 21 ± 2 y, 6 females) completed 5 min of lower body negative pressure (LBNP; -40 mmHg) and 5 min of lower body positive pressure (LBPP; 20 mmHg). Protocols were randomized and separated by 10 min...
2021: Frontiers in Neurology
https://read.qxmd.com/read/33853405/-11-c-deschloroclozapine-is-an-improved-pet-radioligand-for-quantifying-a-human-muscarinic-dreadd-expressed-in-monkey-brain
#53
JOURNAL ARTICLE
Xuefeng Yan, Sanjay Telu, Rachel M Dick, Jeih-San Liow, Paolo Zanotti-Fregonara, Cheryl L Morse, Lester S Manly, Robert L Gladding, Stal Shrestha, Walter Lerchner, Yuji Nagai, Takafumi Minamimoto, Sami S Zoghbi, Robert B Innis, Victor W Pike, Barry J Richmond, Mark Ag Eldridge
Previous work found that [11 C]deschloroclozapine ([11 C]DCZ) is superior to [11 C]clozapine ([11 C]CLZ) for imaging Designer Receptors Exclusively Activated by Designer Drugs (DREADDs). This study used PET to quantitatively and separately measure the signal from transfected receptors, endogenous receptors/targets, and non-displaceable binding in other brain regions to better understand this superiority. A genetically-modified muscarinic type-4 human receptor (hM4 Di) was injected into the right amygdala of a male rhesus macaque...
April 14, 2021: Journal of Cerebral Blood Flow and Metabolism
https://read.qxmd.com/read/33692132/a-first-in-human-phase-0-clinical-study-of-rna-interference-based-spherical-nucleic-acids-in-patients-with-recurrent-glioblastoma
#54
JOURNAL ARTICLE
Priya Kumthekar, Caroline H Ko, Tatjana Paunesku, Karan Dixit, Adam M Sonabend, Orin Bloch, Matthew Tate, Margaret Schwartz, Laura Zuckerman, Ray Lezon, Rimas V Lukas, Borko Jovanovic, Kathleen McCortney, Howard Colman, Si Chen, Barry Lai, Olga Antipova, Junjing Deng, Luxi Li, Serena Tommasini-Ghelfi, Lisa A Hurley, Dusten Unruh, Nitya V Sharma, Manoj Kandpal, Fotini M Kouri, Ramana V Davuluri, Daniel J Brat, Miguel Muzzio, Mitchell Glass, Vinod Vijayakumar, Jeremy Heidel, Francis J Giles, Ann K Adams, C David James, Gayle E Woloschak, Craig Horbinski, Alexander H Stegh
Glioblastoma (GBM) is one of the most difficult cancers to effectively treat, in part because of the lack of precision therapies and limited therapeutic access to intracranial tumor sites due to the presence of the blood-brain and blood-tumor barriers. We have developed a precision medicine approach for GBM treatment that involves the use of brain-penetrant RNA interference-based spherical nucleic acids (SNAs), which consist of gold nanoparticle cores covalently conjugated with radially oriented and densely packed small interfering RNA (siRNA) oligonucleotides...
March 10, 2021: Science Translational Medicine
https://read.qxmd.com/read/33485596/reversible-cerebral-vasoconstriction-syndrome-associated-with-hyperosmolar-hyperglycaemic-state-a-case-report-and-literature-review
#55
REVIEW
Barry Ting Sheen Kweh, Terence Tan, Andrew Morokoff
Reversible cerebral vasoconstriction syndrome (RCVS) is an uncommon disorder characterised by thunderclap headache and self-resolving angiographic vasospasm in the presence or absence of neurological deficit. We present the first case of RCVS likely precipitated by a complex array of confounding factors including a hyperosmolar hyperglycaemic state (HHS), induction chemotherapy with cyclophosphamide, non-Hodgkin's lymphoma, pancytopenia and previous blood transfusions. However, the clinical presentation in this case of altered conscious state followed by thunderclap headache was highly suggestive of HHS being the crucial inciting factor...
February 2021: Journal of Clinical Neuroscience: Official Journal of the Neurosurgical Society of Australasia
https://read.qxmd.com/read/33459038/symptoms-upon-postural-change-and-orthostatic-hypotension-in-adolescents-with-concussion
#56
JOURNAL ARTICLE
M Nadir Haider, Kush S Patel, Barry S Willer, Victoria Videira, Charles G Wilber, Andrew R Mayer, Christina L Master, Brandon L Mariotti, Christopher Wertz, Eileen P Storey, Kristy B Arbogast, Grace Park, Scott J Oglesbee, Itai Bezherano, Kenneth Aguirre, Jesse G Fodero, Blair D Johnson, Rebekah Mannix, Jeffrey C Miecznikowski, John J Leddy
Objective : Concussion is associated with dysautonomia, altered blood pressure (BP) control, and may cause Orthostatic Hypotension (OH). We measured prevalence of OH using the 1-minute supine-to-standing OH Test in adolescents with concussion and controls. Participants : Adolescents within 10 days of injury (Concussion Group, n = 297, 15.0 ± 1.7 years, 59% male) were compared with controls (Control Group, n = 214, 15.0 ± 1.5 years, 58% male). Methods : BP, heart rate (HR), and complaints of lightheadedness/dizziness were measured after 2-minute supine and 1-minute standing...
January 17, 2021: Brain Injury
https://read.qxmd.com/read/33212192/pharmacokinetics-and-efficacy-of-atropine-sulfate-obidoxime-chloride-co-formulation-against-vx-in-a-guinea-pig-model
#57
JOURNAL ARTICLE
Jiska Kentrop, Vladimir Savransky, Steven D Klaassen, Tomas van Groningen, Sara Bohnert, Alex S Cornelissen, Laura Cochrane, John Barry, Marloes J A Joosen
Nerve agent exposure is generally treated by an antidote formulation composed of a muscarinic antagonist, atropine sulfate (ATR), and a reactivator of acetylcholinesterase (AChE) such as pralidoxime, obidoxime (OBI), methoxime, trimedoxime or HI-6 and an anticonvulsant. Organophosphates (OPs) irreversibly inhibit AChE, the enzyme responsible for termination of acetylcholine signal transduction. Inhibition of AChE leads to overstimulation of the central and peripheral nervous system with convulsive seizures, respiratory distress and death...
November 16, 2020: Regulatory Toxicology and Pharmacology: RTP
https://read.qxmd.com/read/33074237/benfotiamine-and-cognitive-decline-in-alzheimer-s-disease-results-of-a-randomized-placebo-controlled-phase-iia-clinical-trial
#58
RANDOMIZED CONTROLLED TRIAL
Gary E Gibson, José A Luchsinger, Rosanna Cirio, Huanlian Chen, Jessica Franchino-Elder, Joseph A Hirsch, Lucien Bettendorff, Zhengming Chen, Sarah A Flowers, Linda M Gerber, Thomas Grandville, Nicole Schupf, Hui Xu, Yaakov Stern, Christian Habeck, Barry Jordan, Pasquale Fonzetti
BACKGROUND: In preclinical models, benfotiamine efficiently ameliorates the clinical and biological pathologies that define Alzheimer's disease (AD) including impaired cognition, amyloid-β plaques, neurofibrillary tangles, diminished glucose metabolism, oxidative stress, increased advanced glycation end products (AGE), and inflammation. OBJECTIVE: To collect preliminary data on feasibility, safety, and efficacy in individuals with amnestic mild cognitive impairment (aMCI) or mild dementia due to AD in a placebo-controlled trial of benfotiamine...
2020: Journal of Alzheimer's Disease: JAD
https://read.qxmd.com/read/33067719/effect-of-ergothioneine-on-7-ketocholesterol-induced-endothelial-injury
#59
JOURNAL ARTICLE
Sally Shuxian Koh, Samantha Chia-Yi Ooi, Natalie Man-Yin Lui, Cao Qiong, Leona Ting-Yuke Ho, Irwin Kee-Mun Cheah, Barry Halliwell, Deron R Herr, Wei-Yi Ong
Ergothioneine (ET) is a naturally occurring antioxidant that is synthesized by non-yeast fungi and certain bacteria. ET is not synthesized by animals, including humans, but is avidly taken up from the diet, especially from mushrooms. In the current study, we elucidated the effect of ET on the hCMEC/D3 human brain endothelial cell line. Endothelial cells are exposed to high levels of the cholesterol oxidation product, 7-ketocholesterol (7KC), in patients with cardiovascular disease and diabetes, and this process is thought to mediate pathological inflammation...
March 2021: Neuromolecular Medicine
https://read.qxmd.com/read/32897518/effects-of-antimalarial-drugs-on-neuroinflammation-potential-use-for-treatment-of-covid-19-related-neurologic-complications
#60
REVIEW
Wei-Yi Ong, Mei-Lin Go, De-Yun Wang, Irwin Kee-Mun Cheah, Barry Halliwell
The SARS-CoV-2 virus that is the cause of coronavirus disease 2019 (COVID-19) affects not only peripheral organs such as the lungs and blood vessels, but also the central nervous system (CNS)-as seen by effects on smell, taste, seizures, stroke, neuropathological findings and possibly, loss of control of respiration resulting in silent hypoxemia. COVID-19 induces an inflammatory response and, in severe cases, a cytokine storm that can damage the CNS. Antimalarials have unique properties that distinguish them from other anti-inflammatory drugs...
January 2021: Molecular Neurobiology
keyword
keyword
108492
3
4
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.